Abstract

Vedolizumab, a humanized monoclonal antibody to the α4β7 integrin, reduces lymphocyte trafficking to the intestine.

Tags

Antibodies, Monoclonal, Crohn's Disease, Drug Therapy, Ulcerative Colitis, therapeutic use, Gastrointestinal Agents, Adverse Effects

Read More